InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Glickman Sarah JS, Chief Financial Officer. Officer active across 3 companies, notably bluebird bio, Inc.. In total, 8 reports have been published. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
04,200 shares0
Common Stock
SEC:0001562180-22-004991:0·
036,808 shares0
Ordinary Shares
SEC:0001576427-22-000014:0·
0
Common Stock
SEC:0001628280-21-023646:0·
03,002 shares0
Common Stock
SEC:0001628280-21-023466·
03,002 shares0
Common Stock
SEC:0001628280-21-023466:0·
04,663 shares0
Common Stock
SEC:0001562180-21-006221·
04,663 shares0
Common Stock
SEC:0001562180-21-006221:0·
8 of 8 declarations
About Glickman Sarah JS
Sarah JS Glickman is a Board Member and Chief Financial Officer at bluebird bio, Inc., 2seventy bio, Inc., and Criteo S.A. She oversees financial operations and is responsible for strategic planning. Her role is crucial in ensuring the financial health of these companies and supporting their growth in the biopharmaceutical sector.
